학술논문
Adherence to dabigatran etexilate in atrial fibrillation patients intended to undergo electrical cardioversion.
Document Type
Article
Author
Source
European Heart Journal - Cardiovasular Pharmacotherapy; April 2019, Vol. 5 Issue: 2 p91-99, 9p
Subject
Language
ISSN
20556837; 20556845
Abstract
Effective anticoagulation in patients undergoing electrical cardioversion (ECV) for symptomatic atrial fibrillation is important to prevent adverse events. High medication adherence is a requirement. In patients with newly diagnosed atrial fibrillation (n = 169) who were intended to undergo ECV, the aim of this study was to measure self-reported short- and long-term adherence, evaluate whether dabigatran plasma concentrations reflect adherence, measure treatment satisfaction and assess whether adherence and treatment satisfaction are correlated.